Monaco Asset Management SAM
- SEC CIK
- 0001803593
- Latest filing
- Aug 7, 2026
MRVI holding history
Maravai Lifesciences Holdings, Inc. in every 13F filed by Monaco Asset Management SAM, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRVI overviewAll 13F holders of MRVIFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,231,026
- Value
- $13.9M
- % of portfolio
- 5.2%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,231,026 | $13.9M | 5.2% | −1,189,994−34.8% | Reduced | Holders |
| Q1 2026 | 3,421,020 | $9.68M | 3.1% | −39,170−1.1% | Reduced | Holders |
| Q4 2025 | 3,460,190 | $11.2M | 3.3% | −196,147−5.4% | Reduced | Holders |
| Q3 2025 | 3,656,337 | $10.5M | 3.9% | +2,775,372+315.0% | Added | Holders |
| Q2 2025 | 880,965 | $2.12M | 0.8% | +45,100+5.4% | Added | Holders |
| Q1 2025 | 835,865 | $1.85M | 0.9% | +544,501+186.9% | Added | Holders |
| Q4 2024 | 291,364 | $1.59M | 0.7% | +216,364+288.5% | Added | Holders |
| Q3 2024 | 75,000 | $623.3K | 0.3% | −125,000−62.5% | Reduced | Holders |
| Q2 2024 | 200,000 | $1.43M | 0.7% | +41,849+26.5% | Added | Holders |
| Q1 2024 | 158,151 | $1.37M | 0.6% | −153,059−49.2% | Reduced | Holders |
| Q4 2023 | 311,210 | $2.04M | 0.8% | +311,210 | New | Holders |